DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
Jennifer L. Guerriero(Brigham and Women's Hospital), Wei‐Xing Zong(Rutgers, The State University of New Jersey)
Cited by 87
Related Papers
Necrotic death as a cell fate
|Genes & Development|2006|901
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
|Cancer Cell|2021|624
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
|Nature Cancer|2020|271
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
|Cancer Research|2016|140
Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition
|Journal of Biological Chemistry|2009|117